New in CME Courses: How to Incorporate GLP-1 RA and Basal Insulin in Practice

Treatment Intensification: How to Incorporate GLP-1 RA and Basal Insulin in Practice
Target audience: Primary Care Providers, Nurse Practitioners, Physician Assistants
Type 2 diabetes (T2DM) is one of the most common and challenging conditions encountered by primary care clinicians. Achieving and maintaining glycemic goals in patients with T2DM requires frequent assessments and individualized adjustments to therapy. New agents and combinations – including SGLT-2 inhibitors, GLP-1 receptor agonists (RA), and fixed-ratio basal insulin/GLP-1 RA – expand clinicians’ options to safely manage hyperglycemia. However, incorporating these agents into clinical practice can be challenging.
In this unique game-style activity, you will participate in the management of a virtual patient and rank therapeutic options at each decision point. Expert faculty will rank the same options and provide an evidence-based rationale for their choices.
This activity, Treatment Intensification: How to Incorporate GLP-1 RA and Basal Insulin in Practice offers 0.75 AMA PRA Category 1 Credit

Click here to start this engaging activity!